SCHEMBL13791853

SCHEMBL13791853

CNC(=O)OCC1(NC(C)C)CCCCC1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CHRNB2 P17787 2/20 0.37
▸ CHRNA4 P43681 2/20 0.37
▸ CHRM2 P08172 1/20 0.33
▸ CHRM4 P08173 1/20 0.33
▸ CHRM5 P08912 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ CHRM1 P11229 1/20 0.33
▸ NFKB1 P19838 1/20 0.33
▸ CHRM3 P20309 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ CHRNA7 P36544 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ APEX1 P27695 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ EPHX1 P07099 1/20 0.33
▸ CYP3A4 P08684 1/20 0.31
▸ CYP1A2 P05177 1/20 0.30
▸ CYP2C9 P11712 1/20 0.30
▸ DPP4 P27487 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12584816 0.84 CHRNB2 (0.36) CHRNB2CHRNA4CHRM2CHRM4CHRM5
SCHEMBL13792022 0.84 ALDH1A1 (0.45) CHRNB2CHRNA4APEX1SMN1; SMN2EPHX1
SCHEMBL13792021 0.79 CHRNB2 (0.38) CHRNB2CHRNA4CHRM2CHRM4CHRM5
SCHEMBL13804483 0.70 ALDH1A1 (0.47) CHRNB2CHRNA4LMNASMN1; SMN2EPHX1
SCHEMBL23086622 0.69 CHRNB2 (0.35) CHRNB2CHRNA4CHRM2CHRM4CHRM5
SCHEMBL28632681 0.69 CHRNB2 (0.41) CHRNB2CHRNA4CHRM2CHRM4CHRM5
SCHEMBL24004507 0.68 MME (0.35) DPP4
SCHEMBL17035460 0.67 CHRNB2 (0.39) CHRNB2CHRNA4CHRM2CHRM4CHRM5
SCHEMBL24991672 0.67 CYP1A2 (0.34) CHRNB2CHRNA4CHRM2CHRM4CHRM5
SCHEMBL23086905 0.67 EPHX1 (0.36) CHRNB2CHRNA4CHRM2CHRM4CHRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7550559-B2 Acylsulfonamide compounds as inhibitors of hepatitis C virus NS3 serine protease SCHERING CORPORATION (US) 2009-06-23 — — US disclosed
US-7399749-B2 Substituted prolines as inhibitors of hepatitis C virus NS3 serine protease SCHERING CORPORATION (US) 2008-07-15 — — US disclosed
US-7342041-B2 3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis C virus NS3 serine protease SCHERING CORPORATION (US) 2008-03-11 — — US disclosed
Send feedback